ロード中...
Rituximab mediates loss of CD19 on B cells in the absence of cell death
OBJECTIVE: To evaluate loss of the B cell specific marker CD19 with addition of rituximab (RTX) to healthy donor blood and to determine the role of complement mediated cytotoxicity in these cells. METHODS: Healthy donor whole blood and peripheral blood mononuclear cells (PBMC) were evaluated for los...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3448861/ https://ncbi.nlm.nih.gov/pubmed/22674374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.34560 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|